NCT00419887View on ClinicalTrials.gov

Safety, Tolerability, Effect of Vildagliptin and How the Body Changes the Blood Level of Vildagliptin in Healthy Chinese Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

September 30, 2006

Conditions

Healthy

Interventions

DRUG

Vildagliptin (LAF237)

Trial Locations (1)

Unknown

Novartis, Beijing

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY